250 participants
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2026-11-30
- Completion:
- 2037-11-30
Conditions
- Amyloidosis in Transthyretin (TTR)
- Amyloidosis, Familial
- Amyloid Cardiomyopathy
- Amyloid Cardiomyopathy, Transthyretin-Related
- Amyloidogenic Transthyretin (ATTR) Amyloidosis
- Heart Disease
- Cardiomyopathies
- Amyloidosis, Hereditary, Transthyretin-Related
- Polyneuropathies
- Amyloidosis
Interventions
- DRUG
No Results Yet